Piper Sandler: 'Is now the time to buy STERIS (STE)?'
Tweet Send to a Friend
Piper Sandler analyst Jason Bednar reiterated an Overweight rating and $270.00 price target on STERIS (NYSE: STE).The analyst commented: "Is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


